BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X952. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,356,760 | -33.1% | 172,000 | -18.4% | 0.00% | 0.0% |
Q1 2024 | $6,514,844 | +452.7% | 210,700 | +621.6% | 0.00% | – |
Q4 2023 | $1,178,804 | -62.2% | 29,200 | -75.3% | 0.00% | -100.0% |
Q3 2023 | $3,119,571 | -64.3% | 118,300 | -76.7% | 0.00% | -66.7% |
Q2 2023 | $8,742,760 | +91.4% | 508,300 | +84.5% | 0.00% | +50.0% |
Q1 2023 | $4,567,790 | +2025.7% | 275,500 | +877.0% | 0.00% | – |
Q4 2022 | $214,884 | -61.4% | 28,200 | -49.6% | 0.00% | – |
Q3 2022 | $557,000 | +24.9% | 56,000 | +14.1% | 0.00% | – |
Q2 2022 | $446,000 | – | 49,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 200,000 | $3,440,000 | 2.60% |
GROUP ONE TRADING, L.P. | 166,900 | $2,870,680 | 0.01% |
JANE STREET GROUP, LLC | 508,300 | $8,742,760 | 0.00% |
SIMPLEX TRADING, LLC | 215,700 | $3,710 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 23,700 | $407,640 | 0.00% |